Head-to-head · Cost-Efficiency Index
VyrarX vs Elevate Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
VyrarX
Shoppers comparing headline GLP-1 starting prices who don't need pharmacy/clinical-leadership transparency up front.
Visit VyrarXElevate Health
Shoppers comparing low-entry-cost financed GLP-1 plans -- but only after confirming which 'Elevate Health' company a link actually leads to.
Visit Elevate HealthThe verdict
VyrarX takes it, leading the Cost-Efficiency Index 49 to 48. VyraRx is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with physician oversight, claiming coverage in 47 states and displaying a LegitScript seal. Elevate Health still earns a C — Shoppers comparing low-entry-cost financed GLP-1 plans -- but only after confirming which 'Elevate Health' company a link actually leads to.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs VyrarX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | VyrarX | Elevate Health |
|---|---|---|
| Cost-Efficiency Index | 49/100 | 48/100 |
| Semaglutide / mo | Not disclosed | $114/mo (compounded) |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | $1,368 |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #428 | #434 |
VyrarX
49/100Where the value is
- Clear headline pricing for both semaglutide and tirzepatide
- Claims broad 47-state coverage
- LegitScript seal displayed on the homepage
The tradeoffs
- No named medical director or clinical leadership anywhere on the public site
- No named compounding pharmacy partner disclosed
Elevate Health
48/100Where the value is
- Company A offers $0-down financing via Afterpay/Klarna, lowering the barrier to start
- Company B is LegitScript certified and states nationwide (50-state) coverage
- Both explicitly name semaglutide as the active medication
The tradeoffs
- Genuine naming collision between two different operators sharing 'Elevate Health' branding -- high risk of shopper confusion
- Company A's $114 headline is a discounted first-order price with dose-escalation pricing left unstated
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.